Early Stage Clinical Studies for Drugs and Devices
This course is not currently scheduled. Click on the Notify Me button to the left to be notified when it is scheduled.
This course is available as a client site course. Please click here for more information.
Who Should Attend
This course will benefit those in the pharmaceutical, medical
device and biologics industries especially:-
Personnel in development and clinical evaluation
- Scientists who have specialized in other areas and wish
to master the basics of the regulatory and technical
requirements and challenges involved in clinical
development
- Regulatory and managerial personnel involved with planning
project management and creation of development and
regulatory strategies
- Personnel with limited development experience
- Newly hired employees of established companies whose
responsibilities include new products evaluated in humans
Description
This two-day course will give a comprehensive overview of
the regulatory requirements, design, conduct and analysis of
FIM (first in man) studies of new drugs, biologics and medical
devices in human beings. The participant will come away
knowing what must be done and what cannot be done for,
and in, such studies and how these fit into the development
process.
Other Courses of Interest
Auditing and Inspecting Preclinical Research for GLP Compliance
Biosafety of Biological Drug Products
Developing Specifications for Drug Substances and Drug Products
Oct 15 2012, Amsterdam, The Netherlands
Drug Regulatory Compliance/Drug Approval and Preapproval Inspection
Good Laboratory Practices (GLP)
Jun 18 2012, Amsterdam, The Netherlands
Good Laboratory Practices (GLP)
Nov 05 2012, New Brunswick, NJ
Non-Clinical Drug Safety Evaluation and Drug Development
Oct 08 2012, Amsterdam, The Netherlands
Pathways to Skin Penetration
Jun 04 2012, New Brunswick, NJ
Pathways to Skin Penetration
Nov 08 2012, Amsterdam, The Netherlands
Related Industries